Photocure news
WebFeb 23, 2024 · Photocure ASA (OSE: PHO) today reported Hexvix®/Cysview® revenues of NOK 94.9 million in the fourth quarter of 2024 (Q4 2024: NOK 94.2 million), and an EBITDA of minus NOK 16.9 million (NOK -5.5 ... WebPhotocure ASA is a Norwegian specialty pharma company that develops and sells pharmaceuticals and medical devices based on proprietary photodynamic technology. …
Photocure news
Did you know?
WebMay 11, 2024 · Oslo, Norway, 11 May 2024: Photocure ASA (OSE:PHO) today reported Hexvix®/Cysview® revenues of NOK 81.4 million in the first quarter of 2024 (Q1 2024: … WebMay 19, 2024 · Photocure reported total group revenues of NOK 88.2 million in the first quarter of 2024 ( NOK 55.0 million ), with an EBITDA* before restructuring of NOK 18.1 …
WebMar 30, 2024 · Photocure Technology; Our products; Research support; News; Our Impact. Patient Registries And Real-World Evidence; Bladder cancer community support; … WebAug 25, 2024 · The parties entered into a final agreement today, stipulating that commercial rights will transfer to Photocure on January 1st, 2024. The reacquisition of marketing and distribution rights enables ...
WebApr 12, 2024 · OSLO, Norway, April 12, 2024 /PRNewswire/ -- Photocure ASA today announces the publication of the Annual Report and integrated ESG report for 2024. The … WebApr 11, 2024 · Price History & Performance. Summary of all time highs, changes and price drops for Photocure. Historical stock prices. Current Share Price. kr57.90. 52 Week High. kr119.90. 52 Week Low. kr54.80.
WebFeb 7, 2024 · "The successful FDA approval is great news for the bladder cancer community in the U.S.," commented Geoffrey Coy, Vice President and General Manager, North America at Photocure.
WebAug 10, 2024 · Photocure ASA (OSE:PHO) today reported Hexvix®/Cysview® revenues of NOK 99.9 million in the second quarter of 2024 (Q1 2024: NOK 88.9 million), and a positive EBITDA of NOK 1.4 million (NOK 5.8 ... the pubic bones meet anteriorly at theWebFeb 23, 2024 · OSLO, Norway, Feb. 23, 2024 /PRNewswire/ -- Photocure ASA (OSE: PHO) today reported Hexvix®/Cysview® revenues of NOK 94.9 million in the fourth quarter of 2024 (Q4 2024: NOK 94.2 million), and ... significance of 7 horsesWebMar 14, 2024 · Photocure is commercializing Cysview/Hexvix directly in the U.S. and Europe and has strategic partnerships for the commercialization of Hexvix/Cysview in China, Chile, Australia, New Zealand and ... significance of 7 fishes at christmas eveWebAug 10, 2024 · OSLO, Norway, Aug. 10, 2024 /PRNewswire/ -- Photocure ASA (OSE:PHO) today reported Hexvix®/Cysview® revenues of NOK 99.9 million in the second quarter of 2024 (Q1 2024: NOK 88.9 million), and a ... the pub hayfield mnWebApr 12, 2024 · OSLO, Norway, April 12, 2024 /PRNewswire/ -- Photocure ASA today announces the publication of the Annual Report and integrated ESG report for 2024. The Board of Directors of Photocure ASA has ... significance of 66 in the bibleWebHuman Resources at Photocure ASA. The position of Account Manage r is responsible for growing Cysview® sales in New England territory. Responsibilities include account … significance of 4 leaf cloverWebMar 14, 2024 · OSLO, Norway, March 14, 2024 /PRNewswire/ -- Photocure ASA(OSE: PHO), the Bladder Cancer Company, announces its participation in the congress, and two abstract presentations at the European Association of Urology congress (EAU) in Milan, Italy, highlighting the benefits of Blue Light Cystoscopy (BLC ®) in Bladder Cancer … the pub hinckley il